NICE recommends semaglutide for obesity treatmentThousands of people living with obesity are set to benefit from a new drug which has helped those using it to reduce their weight by more...
nanoMesh files second PMA (510(k)) with FDA for Exogenesis Hernia MeshnanoMesh, a subsidiary of Exogenesis, has successfully completed filing of a second Pre-Marketing Notification Application (510(k)) with...
Liraglutide after RYGB results in significant weight loss and resolution of obesity-related conditions1 day ago
Discovery of Neuropeptide Y could lead to simpler and cheaper drugs to control obesity and weight gain2 days ago